Themis Medicare Ltd. (THEMISMED) Share Price Rises 9.12% to Rs 131.6

Themis Medicare Ltd. Share Price is in focus after the stock rose 9.12% today to Rs 131.6, up Rs 11 from the previous close of Rs 120.6. The company’s market capitalisation stands at Rs 1,110.73 crore, placing the move firmly in the mid-cap healthcare conversation on Stock Market Today. According to latest Univest data, the price event is confirmed, but the figures do not establish a company-specific catalyst. That matters because investors tracking Themis Medicare Ltd. Stock News usually want to know whether a rise reflects fresh business news, a broad sector move, or simple market re-rating. In this case, the verified data supports the share price rise and points investors toward valuation, sector positioning and company financials for context. Univest data also shows turnover of Rs 0.41 crore, which helps frame the intensity of the day’s price action.

Themis Medicare Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 131.6
Previous Close	Rs 120.6
Today's Move	Rs 11 (+9.12%)
Open	Rs 119.05
High	Rs 133.95
Low	Rs 119.05
Turnover	Rs 0.41 crore
Market Capitalisation	Rs 1,110.73 crore
Market Cap Category	Small Cap

Themis Medicare Ltd. (THEMISMED) rose to Rs 131.6 from the previous close of Rs 120.6, a move of Rs 11 or 9.12%. The stock opened at Rs 119.05, reached a high of Rs 133.95, recorded a low of Rs 119.05.

Themis Medicare Ltd. Share Price Today moved from an open of Rs 119.05 to a high of Rs 133.95, with the low also at Rs 119.05. That range shows a steady upward move from the opening print, and the stock was last traded at Rs 131.6 during the market window covered here. Themis Medicare Share Price therefore remains one of the more notable Stocks Rising Today, even though the verified record does not identify a specific trigger. For readers scanning Themis Medicare Ltd. Stock News and Themis Medicare News Today, the key takeaway is straightforward: price action was positive, the move was measurable, and the stock remained active enough to stay on market trackers such as Univest and other Indian Stock Market screens.

Themis Medicare Ltd. (THEMISMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,110.73 crore
P/E Ratio	27.79x
P/B Ratio	2.86x
ROE	7.65%
ROCE	10.37%
EPS	Rs 4.34
Book Value Per Share	Rs 42.13
Dividend Yield	0.41%

Themis Medicare Ltd. (THEMISMED) fundamental metrics show P/E 27.79x, P/B 2.86x, ROE 7.65%, ROCE 10.37%. These figures provide context only and are not a buy or sell signal.

Themis Medicare Ltd. has a market capitalisation of Rs 1110.73 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.79x, P/B at 2.86x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.65% and ROCE of 10.37%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.34, book value per share of Rs 42.13, dividend yield of 0.41%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	27.79x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	2.86x
Benchmark Median P/B	2.92x
Company ROE	7.65%
Benchmark Median ROE	11.78%
Company ROCE	10.37%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 1,110.73 crore
Benchmark Median Market Cap	Rs 674.09 crore

Themis Medicare Ltd. (THEMISMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Themis Medicare Ltd. (THEMISMED) has a P/E ratio of 27.79x, which is below the benchmark median of 32.83x, a difference of -15.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Themis Medicare Ltd. (THEMISMED) has a ROE of 7.65%, which is below the benchmark median of 11.78%, a difference of -35.06%. Themis Medicare Ltd. (THEMISMED) has a ROCE of 10.37%, which is below the benchmark median of 13.65%, a difference of -24.03%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Themis Medicare Ltd. (THEMISMED) has a P/E ratio of 27.79x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.65% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.37% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Themis Medicare Ltd. (THEMISMED) has a market capitalisation of Rs 1,110.73 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Themis Medicare Ltd.

• Themis Medicare Ltd. Share Price rose 9.12% today to Rs 131.6, making it a visible name among Stocks in News.
• The day’s range from Rs 119.05 to Rs 133.95 shows decisive price action during the market window.
• Valuation at 27.79 times earnings is below the same-industry median, which keeps Themis Medicare Share Price on value screens.
• ROE of 7.65% and ROCE of 10.37% give investors a clear financial context for Themis Medicare Ltd. Share Price Today.
• Healthcare peer comparison helps explain why Univest is tracking Themis Medicare Stock News alongside larger pharma names.

About Themis Medicare Ltd.

Themis Medicare Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s latest market profile places it among mid-sized listed healthcare names with a market capitalisation of Rs 1,110.73 crore. Investors tracking Themis Medicare Ltd. Share Price often look at the business through the lens of profitability and valuation rather than scale alone. Based on the latest Univest figures, the company’s core investment case is tied to its financial ratios, earnings per share of Rs 4.34, book value of Rs 42.13 and dividend yield of 0.41%.

For readers following Themis Medicare Ltd. Stock News or Themis Medicare Ltd. Share News, the useful angle is that the company sits in a competitive pharmaceutical universe where market pricing often reflects a mix of margins, capital efficiency and relative size. That makes Themis Medicare Share Price relevant not only as a daily market move but also as a stock to track against peers in the healthcare industry.

Frequently Asked Questions

Why did Themis Medicare Ltd. Share Price rise today?

Ans. The latest Univest data confirms a 9.12% rise to Rs 131.6, but it does not identify a company-specific trigger. Investors can still read the move alongside valuation, sector context and the day’s price range.

What is Themis Medicare Ltd. Share Price Today?

Ans. Themis Medicare Ltd. Share Price Today is Rs 131.6, compared with the previous close of Rs 120.6. The stock gained Rs 11 intraday, keeping it in focus among healthcare shares.

How much did Themis Medicare Ltd. stock gain today?

Ans. The stock gained 9.12% today, which equals Rs 11 on the latest print. That move lifted Themis Medicare Share Price from Rs 120.6 to Rs 131.6 during the market window.

What is the market capitalisation of Themis Medicare Ltd.?

Ans. Themis Medicare Ltd. has a market capitalisation of Rs 1,110.73 crore. That places the company above the same-industry median in size, while still well below the sector’s largest listed pharmaceutical names.

How is Themis Medicare Ltd. valued on earnings and book value?

Ans. The stock trades at a P/E ratio of 27.79 and a P/B ratio of 2.86. EPS is Rs 4.34 and book value is Rs 42.13, which gives a clear valuation and asset base context.

What do Themis Medicare Ltd. profitability ratios show?

Ans. ROE is 7.65% and ROCE is 10.37%. Those figures are below the same-industry medians, so the stock’s share price rise needs to be read with financial quality in mind.

How does Themis Medicare Ltd. compare with healthcare peers?

Ans. Compared with listed peers such as Sun Pharma, Cipla and Zydus Lifesciences, Themis Medicare has a smaller market cap and lower ROE and ROCE. Its P/E is also below most of those peers.

What should investors monitor next in Themis Medicare Share Price?

Ans. Investors can monitor how Themis Medicare Share Price behaves relative to Rs 131.6, along with turnover, sector sentiment and any company news. Univest also tracks ratios, market cap and 52-week levels for context.

Track Themis Medicare Ltd. Share Price on Univest

Use Themis Medicare Ltd. (THEMISMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Themis Medicare Ltd. Share Price on Univest for live price updates, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield, 52-week levels and sector insights. Univest helps readers follow Themis Medicare Share Price Today, Themis Medicare Ltd. Stock News and broader market context in one place.